𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Patient and organizational factors related to education and support use by Veterans with Parkinson's disease

✍ Scribed by Terri K. Pogoda; Irene E. Cramer; Mark Meterko; Hai Lin; Ann Hendricks; Robert G. Holloway; Martin P. Charns


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
95 KB
Volume
24
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Patient education and support services are recognized in the Department of Veterans Affairs (VA) as important to the patient‐centered treatment of Parkinson's disease. Indeed, educating patients is one of the missions of the VA's six specialty Parkinson's Disease Research, Education and Clinical Centers (PADRECCs). We compared VA education/support services utilization by whether or not a patient's VA Medical Center (VAMC) contained a PADRECC. Our sample included Parkinson's disease patients from VAMCs with (n = 882) and without (n = 1,448) PADRECCs. Patients completed surveys that asked about demographic/individual characteristics, health status/function, and education/support utilization. Results showed that 15.8% (n = 354) of all patients utilized education/support services. Patients at PADRECC VAMCs were generally healthier and more educated than other VAMC patients. After statistically controlling for these differences, however, being a patient at a PADRECC VAMC site and using only VA providers (as compared to a combination of VA and non‐VA providers) were significant predictors of education/support utilization. Further, proportionally more PADRECC VAMC site patients reported higher satisfaction and receiving a broad range of information from different modalities as compared to other VAMC patients. These findings suggest that PADRECC VAMCs are providing educational/support activities consistent with these specialty centers' goals. © 2009 Movement Disorder Society


📜 SIMILAR VOLUMES


Activation of the extracellular signal-r
✍ Niklas Lindgren; Rehana K. Leak; Kirsten M. Carlson; Amanda D. Smith; Michael J. 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 851 KB

## Abstract Glial cell line‐derived neurotrophic factor (GDNF) has been shown to be neuroprotective in animal models of the dopamine deficiency in Parkinson's disease. To examine the role of the extracellular signal‐regulated kinases 1 and 2 (ERK1/2) in this process, we infused a single dose of GDN